Low-density lipoprotein receptor-related protein 1 (LRP1), apolipoprotein E receptor-2 (ApoER2), very-low-density lipoprotein receptor (VLDL-R), and other receptors can promote vascular endothelial hyperplasia and increase lipoprotein concentrations. Here, VLDLR is linked to hyperplasia.